國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Integrated omics approaches to infec...

Fatima, Zeeshan.

Integrated omics approaches to infectious diseases

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Integrated omics approaches to infectious diseasesedited by Saif Hameed, Zeeshan Fatima.
其他作者:	Hameed, Saif.
出版者:	Singapore :Springer Singapore :2021.
面頁冊數:	xix, 542 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Communicable diseasesEtiology.
電子資源:	https://doi.org/10.1007/978-981-16-0691-5
ISBN:	9789811606915$q(electronic bk.)

Integrated omics approaches to infectious diseases
Integrated omics approaches to infectious diseases[electronic resource] /edited by Saif Hameed, Zeeshan Fatima. - Singapore :Springer Singapore :2021. - xix, 542 p. :ill., digital ;24 cm.

Chapter 1. Geno-Informatics for Prediction of Virulence and Drug Resistance in Bacterial Pathogens -- Chapter 2. Next Generation Sequencing: Challenges and Opportunities in Tuberculosis Research -- Chapter 3. Deciphering the role of epigenetic reprogramming in host-pathogen interactions -- Chapter 4. Genomic evidence provides the understanding of SARS-CoV-2 composition, divergence and diagnosis -- Chapter 5. Importance of Next Generation Sequencing in Viral Diagnostics -- Chapter 6. Bioinformatics application in CoVID19 -- Chapter 7. Emerging Transcriptomics approaches to decipher Mycobacterial complexities -- Chapter 8. Microarrays: A road map to uncover host pathogen interactions -- Chapter 9. Transcriptional Approach in the Identification of Drug Targets in Candida spp -- Chapter 10. Non-Coding RNA profiling: Potential Application in Infectious Diseases -- Chapter 11. RNA-seq analysis strategies to understand viral pathogenesis -- Chapter 12. Various Transcriptomic approaches & their applications to study small non-coding RNAs in Dengue and other viruses -- Chapter 13. Transcriptomic Approaches in Understanding Sars-COV-2 Infection -- Chapter 14. miRNA target prediction: Overview and applications -- Chapter 15. A Glimpse into Peptidomic Approach -- Chapter 16. Molecular mechanism of action of antimicrobial agents against clinically important human pathogens: A proteomic approach -- Chapter 17. Exploration of the mycobacterial proteome in the pathogenesis of TB: A perspective -- Chapter 18. Pathogenesis of Staphylococcus aureus and proteomic strategies for the identification of drug targets -- Chapter 19. Proteomics in the study of Host-Pathogen interactions -- Chapter 20. Significance of post-translational modifications in Apicomplexan parasites -- Chapter 21. An introduction to computational pipelines for analyzing untargeted metabolomics data for Leishmaniasis -- Chapter 22. Metabolomics: PromisingTool to Study Disease Biomarkers and Host-Pathogen Interactions -- Chapter 23. Lipidomics to study the role of lipid droplets in host-pathogen interactions -- Chapter 24. Lipid structure, function and lipidomic applications -- Chapter 25. Nanoparticles as Therapeutic Nanocargos affecting Epigenome of Microbial Biofilms -- Chapter 26. Malaria in the era of OMICS: Challenges and Way forward -- Chapter 27. Omics Approaches for Infectious Diseases -- Chapter 28. Pathogen-Omics: challenges and prospects in research and clinical settings.

This book examines applications of multi-omics approaches for understanding disease etiology, pathogenesis, host-pathogen interactions. It also analyzes the genetics, immunological and metabolic mechanisms underlying the infections. The book also explores genomics, transcriptomics, translational-omics, and metabolomics approaches to understand the pathogenesis and identify potential drug targets. It reviews the role of epigenetic reprogramming in shaping the host-pathogen interactions and presents bioinformatics application in the identification of drug targets. Further, it examines the potential applications of RNA sequencing and non-coding RNA profiling to identify the pathogenesis. Lastly, it offers the current challenges, technological advances, and prospects of using multi-omics technologies in infectious biology.

ISBN: 9789811606915$q(electronic bk.)

Standard No.: 10.1007/978-981-16-0691-5doiSubjects--Topical Terms:

901213
Communicable diseases
--Etiology.

LC Class. No.: RC112 / .I58 2021

Dewey Class. No.: 616.9

Integrated omics approaches to infectious diseases
LDR:04306nmm a2200325 a 4500 001 605172
003 DE-He213
005 20210718210017.0
006 m d
007 cr nn 008maaau
008 211201s2021 si s 0 eng d
020 $a 9789811606915$q(electronic bk.)
020 $a 9789811606908$q(paper)
024 7 $a 10.1007/978-981-16-0691-5 $2 doi
035 $a 978-981-16-0691-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC112 $b .I58 2021
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 616.9 $2 23
090 $a RC112 $b .I61 2021
245 0 0 $a Integrated omics approaches to infectious diseases $h [electronic resource] / $c edited by Saif Hameed, Zeeshan Fatima.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a xix, 542 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Geno-Informatics for Prediction of Virulence and Drug Resistance in Bacterial Pathogens -- Chapter 2. Next Generation Sequencing: Challenges and Opportunities in Tuberculosis Research -- Chapter 3. Deciphering the role of epigenetic reprogramming in host-pathogen interactions -- Chapter 4. Genomic evidence provides the understanding of SARS-CoV-2 composition, divergence and diagnosis -- Chapter 5. Importance of Next Generation Sequencing in Viral Diagnostics -- Chapter 6. Bioinformatics application in CoVID19 -- Chapter 7. Emerging Transcriptomics approaches to decipher Mycobacterial complexities -- Chapter 8. Microarrays: A road map to uncover host pathogen interactions -- Chapter 9. Transcriptional Approach in the Identification of Drug Targets in Candida spp -- Chapter 10. Non-Coding RNA profiling: Potential Application in Infectious Diseases -- Chapter 11. RNA-seq analysis strategies to understand viral pathogenesis -- Chapter 12. Various Transcriptomic approaches & their applications to study small non-coding RNAs in Dengue and other viruses -- Chapter 13. Transcriptomic Approaches in Understanding Sars-COV-2 Infection -- Chapter 14. miRNA target prediction: Overview and applications -- Chapter 15. A Glimpse into Peptidomic Approach -- Chapter 16. Molecular mechanism of action of antimicrobial agents against clinically important human pathogens: A proteomic approach -- Chapter 17. Exploration of the mycobacterial proteome in the pathogenesis of TB: A perspective -- Chapter 18. Pathogenesis of Staphylococcus aureus and proteomic strategies for the identification of drug targets -- Chapter 19. Proteomics in the study of Host-Pathogen interactions -- Chapter 20. Significance of post-translational modifications in Apicomplexan parasites -- Chapter 21. An introduction to computational pipelines for analyzing untargeted metabolomics data for Leishmaniasis -- Chapter 22. Metabolomics: PromisingTool to Study Disease Biomarkers and Host-Pathogen Interactions -- Chapter 23. Lipidomics to study the role of lipid droplets in host-pathogen interactions -- Chapter 24. Lipid structure, function and lipidomic applications -- Chapter 25. Nanoparticles as Therapeutic Nanocargos affecting Epigenome of Microbial Biofilms -- Chapter 26. Malaria in the era of OMICS: Challenges and Way forward -- Chapter 27. Omics Approaches for Infectious Diseases -- Chapter 28. Pathogen-Omics: challenges and prospects in research and clinical settings.
520 $a This book examines applications of multi-omics approaches for understanding disease etiology, pathogenesis, host-pathogen interactions. It also analyzes the genetics, immunological and metabolic mechanisms underlying the infections. The book also explores genomics, transcriptomics, translational-omics, and metabolomics approaches to understand the pathogenesis and identify potential drug targets. It reviews the role of epigenetic reprogramming in shaping the host-pathogen interactions and presents bioinformatics application in the identification of drug targets. Further, it examines the potential applications of RNA sequencing and non-coding RNA profiling to identify the pathogenesis. Lastly, it offers the current challenges, technological advances, and prospects of using multi-omics technologies in infectious biology.
650 0 $a Communicable diseases $x Etiology. $3 901213
650 1 4 $a Biomedicine, general. $3 853300
650 2 4 $a Parasitology. $3 194533
650 2 4 $a Medical Microbiology. $3 273931
650 2 4 $a Virology. $3 196498
700 1 $a Hameed, Saif. $3 855175
700 1 $a Fatima, Zeeshan. $3 855176
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-0691-5
950 $a Biomedical and Life Sciences (SpringerNature-11642)